Related posts
Monday relief rallyMarkets climb on easing U.S. inflationEarnings mixed, Powell holds ratesThis summary was created by AI, based on 9 opinions in the last 12 months.
Based on the reviews, experts have mixed opinions about Tilray Inc. Some experts are cautious about investing in the cannabis sector and believe that the company is speculative, while others see potential for the company to survive and make strategic moves such as diversifying into alcohol. The company's financial situation and volatile nature are also highlighted in the reviews.
Avoid the sector. High risk, speculative. Doesn't see catalysts to drive the sector higher, especially if Republicans succeed in the US election.
So much wealth got destroyed in the cannabis sector, but Tilray will be one of the survivors. He can't offer a solid opinion about TLRY, because he needs to learn more about it, but he's starting to study the cannabis sector. Something will happen in the U.S. that will make banking for these companies allowable--and this will be a major move.
Bottoming process a good place to buy for investors. Would wait a bit before investing. Not much momentum in company.
Are diversifying away from cannabis into alcohol which diversifies their revenues. They bought Hexo. Interesting company. Also, they hold a lot of cash which will allow them buying more companies.
In past years, executives were lavishly compensated. He owns no cannabis stocks. Have been hopes that the Democrats will decriminalize cannabis and is unlikely to happen. So, these businesses are stuck in no-man's land. For instance, they can't deduct rent from expenses, or can't get bank loans.
Remember, it's a small cap so can be volatile. In the past two months, it's failing to break out. He's cool towards it.
Death spiral. The hype was crazy. None of these companies is going to make any money. Sell it, take the loss, move on. No chance for a rebound.
Tilray Inc. is a American stock, trading under the symbol TLRY-Q on the NASDAQ (TLRY). It is usually referred to as NASDAQ:TLRY or TLRY-Q
In the last year, 5 stock analysts published opinions about TLRY-Q. 1 analyst recommended to BUY the stock. 4 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Tilray Inc..
Tilray Inc. was recommended as a Top Pick by on . Read the latest stock experts ratings for Tilray Inc..
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
5 stock analysts on Stockchase covered Tilray Inc. In the last year. It is a trending stock that is worth watching.
On 2024-09-20, Tilray Inc. (TLRY-Q) stock closed at a price of $1.72.
Florida's upcoming vote to legalize cannabis could impact the industry. So, he will go back to this name after a long call and listen to their conference call.